Plasmafit® Revision Structan® Hip Endoprosthesis Cup
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Trial details
- Who runs it
- Aesculap AG
- Trial code
- NCT04255966
- Record updated
- 6 May 2026
- Original description
The aim of this observational study is to collect clinical and radiological results of the new Plasmafit® Revision Structan® Hip Endoprosthesis Cup in a standard patient population and when used in routine clinical practice.Read full original descriptionShow less
Prospective, Multi-centric, Comparative, Long-term Clinical Follow-Up Study for the Evidence of Safety and Performance Indicators of the Plasmafit® Revision Structan® Hip Endoprosthesis Cup
The aim of this observational study is to collect clinical and radiological results of the new Plasmafit® Revision Structan® Hip Endoprosthesis Cup in a standard patient population and when used in routine clinical practice.
Inclusion: Indication for the cementless Plasmafit® Revision Structan® Hip Endoprosthesis Cup (primary and revision cases, with bone conditions typically demanding a press-fit revision cup); Written informed consent; Cases where a press-fit cup fixation is possible.
Exclusion: Patient has an infection in the hip joint region; Patients < 18 years; Pregnant patients; Patients not able to comply with the study demands, i.e. follow-up visits (mentally or physically).